EUVIMEDEUVIMED entdecken
Crossref

Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database

Zhidong Wang, Cheng Gong, Youpu Zhang, Min Wang, Ce Chao, Yongxiang Qian, Dongmei Di, Bin Wang

Oncology Research and Treatment · 2023 · 46 (12) · 520-529

DOI: 10.1159/000535020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research and Treatment, online erschienen am 14.11.2023. Verfasst von Zhidong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China, wang13183750061@163.com. Hauptthemen laut MEDLINE: Thymoma, Thymus Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Thymoma is a common mediastinal tumor, but few studies have been performed in thymoma patients 80 years or older. This study aimed to analyze the clinical features, treatment modalities, and survival outcomes of thymoma patients at least 80 years old and compare these features to those of patients younger than 80 years old.

Method

Data from thymoma patients in the Surveillance, Epidemiology and End Results database between 2000 and 2019 were selected. Clinical features, treatment modalities of the two age groups were compared. Survival rates were calculated by the Kaplan-Meier method and the log-rank test was used to compare survival rates between two groups. Propensity score matching was used based on whether surgery was performed. Univariate and multivariate Cox proportional-hazards regression analyses were performed to identify independent prognostic factors.

Results

Compared with the younger patients, the patients aged 80 years or older had a similar distribution of Masaoka-Koga tumor stage, a higher proportion of type A thymoma, and a lower recurrence rate in the early stage. In elderly patients after propensity score matching, the overall survival and cancer-specific survival were better in the surgery group with complete resection and compared with patients of different ages, elderly patients showed similar benefit from surgery as younger patients were observed.

Conclusion

In thymoma patients aged 80 years or older, surgery still plays an important role in survival outcome. Compared with younger patients, older patients have unique clinical features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymomaThymus NeoplasmsAgedHumansAged, 80 and overNeoplasm StagingRadiotherapy, AdjuvantPropensity ScorePrognosisRetrospective Studies

Stichwörter der Autor:innen

Elderly thymoma patientsPropensity score matchingSEERSurgerySurvival

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China, wang13183750061@163.com.
  • Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China.

Zitieren

APA

Wang, Z., Gong, C., Zhang, Y., Wang, M., Chao, C., Qian, Y., Di, D., & Wang, B. (2023). Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database. Oncology Research and Treatment, 46(12), 520-529. https://doi.org/10.1159/000535020

Vancouver

Wang Z, Gong C, Zhang Y, Wang M, Chao C, Qian Y, et al. Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database. Oncology Research and Treatment. 2023;46(12):520-529. doi:10.1159/000535020

BibTeX
@article{Wang2023,
  author = {Wang, Zhidong and Gong, Cheng and Zhang, Youpu and Wang, Min and Chao, Ce and Qian, Yongxiang and Di, Dongmei and Wang, Bin},
  title = {Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database},
  journal = {Oncology Research and Treatment},
  year = {2023},
  volume = {46},
  number = {12},
  pages = {520--529},
  doi = {10.1159/000535020}
}
Kostenlos starten →